$KMB

KIMBERLY CLARK CORP (KMB): Results of Operations and Financial Condition

KIMBERLY CLARK CORP (KMB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 kmbq22026ex-991.htm EARNINGS RELEASE Document Exhibit 99.1 Kimberly-Clark Announces Second Quarter and First Half 2026 Results, Updates 2026 Outlook Makes significant strides in strategic transformation while sustaining strong business momentum DALLAS, August 4, 2026 -

Original reporting
Published Aug 4, 2026, 10:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$KMB
Neutral
medium confidence
Mentioned
$KMB
Relevance
8/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KMBNeutralMed
01

Why it matters

Traders can reprice near-term earnings risk from the China diaper disruption while also factoring in margin and productivity improvements that lifted adjusted gross margin and adjusted operating profit.

02

Market read

Adjusted profitability metrics improved year over year, but a discrete China demand disruption introduces near-term estimate uncertainty.

03

What to watch

The release notes multiple offsetting items (tariff refunds, productivity savings, currency, business exits, transformation charges, and tax-rate normalization), so headline EPS may overstate or understate underlying demand trends.

Relevance 8/10Novelty 8/10Timing: pre-market today (8-K earnings release filed Aug 4, 2026)

Background

This is an SEC 8-K with Exhibit 99.1 covering Kimberly-Clark’s Q2 2026 results and an update to 2026 outlook, excluding International Family Care and Professional as discontinued operations.

Company-level read

Ticker impact

$KMBNeutralMedium confidence
Context

Kimberly-Clark reported Q2 2026 results with adjusted EPS $1.80 and flagged a China diaper social-media disruption impacting near-term sales and profits.

Expected impact

Likely two-sided reaction: support from adjusted profitability and productivity savings, offset by China disruption and higher effective tax rate.

Evidence & confidence

The filing provides concrete Q2 financials (net sales, gross margin, adjusted EPS) plus a discrete, company-specific negative factor (China false-allegation disruption) and an outlook update reference, which together can move both earnings expectations and risk premium.

Market effects

Highlights ongoing margin support from productivity/tariff refunds while showing how social-media-driven product allegations can create localized demand shocks in consumer staples.

China diaper sales are explicitly cited as disrupted in Q2 with expected near-term impact, increasing regional demand uncertainty.

Includes progress on strategic transformation and the Kenvue acquisition track, which can affect broader health and wellness supply-chain expectations.

Counterpoint

The China allegations were refuted by independent testing, so the incremental impact may fade faster than the market fears, making the adjusted EPS strength more durable.

Key entities

  • Kimberly-Clark Corporation

    Reported Q2 2026 results, updated 2026 outlook, and disclosed a China diaper sales disruption tied to false social-media allegations.

  • Kenvue

    Kimberly-Clark said its pending acquisition remains on track to close by end of 2026.

  • Suzano

    Company launched a strategic joint venture with Suzano: Arbex.

Related articles

$KMBMed

Kimberly-Clark to Consolidate Operations, Invest in Digital Optimizations Ahead of Kenvue Acquisition

Kimberly-Clark said it will consolidate 6,000 applications and more than 15 ERP systems as it nears completion of its Kenvue acquisition. On an earnings call, COO Russell Torres cited a three-year plan targeting $1.9 million in savings and identified over $600 million of savings, with system integration and supply chain and commercial integration as key drivers.

$KMBMedAI 8/10

False Quality Claims Threaten Kimberly-Clarks Diaper Sales in China: Repercussions and Recovery Strategies

Kimberly-Clark (maker of Huggies) cut its annual profit and sales outlook after social media allegations in China claimed Huggies diapers contained formamide, hurting Q2 sales. The company commissioned an independent government-approved test that refuted the claims, while regulators are investigating. It now expects 2026 organic sales growth about 100 bps below peers and adjusted EPS growth in high single digits.

$KMBMedAI 8/10

Kimberly-Clark Q2 Earnings Call Highlights

Kimberly-Clark (KMB) discussed Q2 results and guidance on an earnings call. Management cited China diaper disruption starting late June as a headwind to organic sales and said it expects about a $70 million operating profit and $0.16 EPS impact in H2. North America shipments fell 1.4% vs consumption up 0.3%, partly from a Los Angeles distribution center fire. The company received a $45 million U.S. tariff refund and expects $150 million gross input-cost headwinds in H2.

$KMBMedAI 8/10

Kimberly-Clark Q2 Earnings Rise Y/Y, Gross Margin Expands

Kimberly-Clark (KMB) reported Q2 2026 adjusted EPS of $2.12, up 10.4% y/y, and sales of $4,189 million, up 0.6% but below the $4,232 million Zacks estimate. Adjusted gross margin rose 190 bps to 38.8%. The company forecasts 2026 organic sales growth about 100 bps below category growth, with mid-single-digit adjusted operating profit growth.

$KMBMed

Kimberly-Clark sales rise 0.6% to $4.2 billion

Kimberly-Clark reported Q2 net sales of $4.2 billion, up 0.6% year over year. Adjusted EPS rose 10.4% to $2.12, and adjusted operating profit increased 6.2% to $757 million. The company revised its 2026 outlook after a disruption affected diaper sales in China. Shares were down 1.5% in premarket.

$KMBMedAI 8/10

Kimberly-Clark Q2 Net Income Declines

Kimberly-Clark (KMB) reported Q2 net income of $345 million versus $509 million a year earlier. EPS attributable to Kimberly-Clark was $1.04 versus $1.53. Net sales were $4.2 billion, up 0.6%, with organic sales broadly flat. The company expects 2026 adjusted operating profit to grow mid-single digits and adjusted EPS from continuing operations to rise high single digits on a constant-currency basis.